Phenomic AI Companies
Phenomic AI uses artificial intelligence to analyze phenotypes in complex disease models, including high-content co-culture and 3D assays, to discover and optimize therapeutics directly against phenotypic assays. The company's drug discovery platform makes it easier for pharmaceutical companies to discover drugs.
Investors
.png)
.png)
Founded Date:
2017-01-01
Estimated Revenue:
$6 million
Total Funding:
11391214.0
Investors Number:
13.0
Employee Number:
5
Last Funding Type:
Seed
Industry:
BioTech & Health Care
Technology:
Artificial Intelligence, Biotechnology, Information Technology, Machine Learning
Headquarters:
Toronto, Ontario, Canada
Funding Status:
Seed
Last Funding Date:
2020-10-07